GXYLT2 Identified as a Key Prognostic Biomarker and Molecular Driver of Aggressiveness in Gastric Cancer
A groundbreaking study recently published in the prestigious journal Genes & Diseases has unveiled the critical role of glucoside xylosyltransferase ...




















